argenx
ISIN US04016X1019
|WKN A2H9WD
Overview
Description
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Netherlands
Financials
Key metrics
| Market capitalisation, EUR | 36,498.28 m |
| EPS, EUR | - |
| P/B ratio | 8.84 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 1,136.08 m |
| Net income, EUR | -273.34 m |
| Profit margin | -24.06% |
What ETF is argenx in?
There are 21 ETFs which contain argenx. All of these ETFs are listed in the table below. The ETF with the largest weighting of argenx is the First Trust NYSE Arca Biotechnology UCITS ETF Acc.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| Xtrackers World Net Zero Pathway Paris Aligned UCITS ETF 1C | 0.09% | Equity World Social/Environmental Climate Change | 1,050 | 0.19% | 28 | +23.39% | DBX0RU | IE000UZCJS58 |
| Harbor Health Care UCITS ETF Accumulating | 2.14% | Equity World Health Care Innovation | 40 | 0.89% | 15 | -0.91% | A2PFPC | IE00BJQTJ848 |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 3.70% | Equity United States Health Care Biotech | 30 | 0.60% | 8 | +15.41% | A2PZBP | IE00BL0L0H60 |
| WisdomTree BioRevolution UCITS ETF USD Acc | 0.78% | Equity World Health Care Social/Environmental Biotech | 89 | 0.45% | 3 | -9.07% | A3CY21 | IE000O8KMPM1 |
| Invesco Nasdaq Next Generation 100 UCITS ETF Acc | 1.24% | Equity United States Technology | 102 | 0.25% | 45 | +23.76% | A2QPVX | IE00BMD8KP97 |
| Amundi Prime Europe UCITS ETF DR (D) | 0.31% | Equity Europe | 415 | 0.05% | 64 | +8.90% | A2PBLF | LU1931974262 |
| L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.48% | Equity World Social/Environmental Innovation | 368 | 0.60% | 4 | +11.47% | A3DHPA | IE000VTOHNZ0 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing | 0.02% | Equity World Multi-Factor Strategy | 3,647 | 0.50% | 67 | +20.43% | WELT0B | IE000FPWSL69 |
| Xtrackers EMU Net Zero Pathway Paris Aligned UCITS ETF 1C | 0.96% | Equity Europe Social/Environmental Climate Change | 140 | 0.15% | 7 | +6.41% | DBX0RW | IE000Y6L6LE6 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.92% | Equity United States Health Care Biotech | 213 | 0.35% | 31 | +10.23% | A2JDYM | IE00BDZVHG35 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating | 0.02% | Equity World Multi-Factor Strategy | 3,647 | 0.50% | 356 | +21.03% | WELT0A | IE0001UQQ933 |
| iShares Nasdaq US Biotechnology UCITS ETF | 1.92% | Equity United States Health Care Biotech | 213 | 0.35% | 439 | +7.30% | A2DWAW | IE00BYXG2H39 |
| Amundi Prime All Country World UCITS ETF UCITS ETF Acc | 0.04% | Equity World | 2,229 | 0.07% | 75 | - | ETF151 | IE0003XJA0J9 |
| L&G Global Equity UCITS ETF | 0.05% | Equity World Social/Environmental | 1,256 | 0.10% | 227 | +30.92% | A2N4PQ | IE00BFXR5S54 |
| L&G Europe ex UK Equity UCITS ETF | 0.39% | Equity Europe Social/Environmental | 322 | 0.10% | 318 | +6.80% | A2N4PS | IE00BFXR5V83 |
| Amundi Prime Eurozone UCITS ETF DR (C) | 0.61% | Equity Europe | 195 | 0.05% | 67 | +9.06% | A2PWMJ | LU2089238112 |
| Amundi Prime Eurozone UCITS ETF DR (D) | 0.61% | Equity Europe | 195 | 0.05% | 30 | +9.57% | A2PBLH | LU1931974429 |
| Xtrackers Europe Net Zero Pathway Paris Aligned UCITS ETF 1C | 0.47% | Equity Europe Social/Environmental Climate Change | 306 | 0.15% | 5 | +6.17% | DBX0SQ | IE0001JH5CB4 |
| Amundi Prime All Country World UCITS ETF UCITS ETF Dist | 0.04% | Equity World | 2,229 | 0.07% | 1,983 | - | ETF150 | IE0009HF1MK9 |
| L&G Pharma Breakthrough UCITS ETF | 2.77% | Equity World Health Care Innovation | 37 | 0.49% | 17 | +4.10% | A2H9XR | IE00BF0H7608 |
| Amundi Prime Europe UCITS ETF DR (C) | 0.31% | Equity Europe | 415 | 0.05% | 56 | +8.64% | A2PWMH | LU2089238039 |
Order fees
Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
Order volume:
| Broker | Rating | Order fee | Stock savings plans | |
|---|---|---|---|---|
 | 0.99€ | 1000 | View offer* | |
 | 0.00€ | 2500 | View offer* | |
 | 0.00€ | 500 | View offer* | |
 | 0.00€ | 400 | View offer* | |
 | 5.90€ | - | View offer* |
Source: justETF Research; As of 12/2024; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.